Big Pharma Split Corp Class A (TO:PRM) — Market Cap & Net Worth
Market Cap & Net Worth: Big Pharma Split Corp Class A (PRM)
Big Pharma Split Corp Class A (TO:PRM) has a market capitalization of $12.60 Million (CA$17.41 Million) as of May 4, 2026. Listed on the TO stock exchange, this Canada-based company holds position #26280 globally and #1077 in its home market, demonstrating a 3.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Big Pharma Split Corp Class A's stock price CA$14.32 by its total outstanding shares 1216038 (1.22 Million). Analyse PRM cash generation efficiency to see how efficiently the company converts income to cash.
Big Pharma Split Corp Class A Market Cap History: 2017 to 2026
Big Pharma Split Corp Class A's market capitalization history from 2017 to 2026. Data shows growth from $6.36 Million to $12.60 Million (8.22% CAGR).
Big Pharma Split Corp Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Big Pharma Split Corp Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.19x
Big Pharma Split Corp Class A's market cap is 6.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.36 Million | $407.11K | $323.22K | 15.61x | 19.67x |
| 2018 | $6.12 Million | $3.23 Million | $2.78 Million | 1.89x | 2.20x |
| 2019 | $7.67 Million | $2.43 Million | $5.83 Million | 3.15x | 1.32x |
| 2020 | $8.06 Million | $589.26K | $265.42K | 13.67x | 30.36x |
| 2021 | $10.12 Million | $5.36 Million | $4.85 Million | 1.89x | 2.09x |
| 2022 | $10.96 Million | $3.71 Million | $3.15 Million | 2.95x | 3.49x |
| 2023 | $11.27 Million | $311.76K | -$139.68K | 36.16x | N/A |
| 2024 | $11.44 Million | $1.85 Million | -$538.62K | 6.19x | N/A |
Competitor Companies of PRM by Market Capitalization
Companies near Big Pharma Split Corp Class A in the global market cap rankings as of May 4, 2026.
Key companies related to Big Pharma Split Corp Class A by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #140 globally with a market cap of $155.79 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #245 globally with a market cap of $99.82 Billion USD ( CA$137.99 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #267 globally with a market cap of $94.60 Billion USD.
- KKR & Co LP (NYSE:KKR): Ranked #280 globally with a market cap of $92.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | BlackRock Inc | NYSE:BLK | $155.79 Billion | $1061.68 |
| #245 | Brookfield Corporation | TO:BN | $99.82 Billion | CA$61.48 |
| #267 | Blackstone Group Inc | NYSE:BX | $94.60 Billion | $126.35 |
| #280 | KKR & Co LP | NYSE:KKR | $92.43 Billion | $103.68 |
Big Pharma Split Corp Class A Historical Marketcap From 2017 to 2026
Between 2017 and today, Big Pharma Split Corp Class A's market cap moved from $6.36 Million to $ 12.60 Million, with a yearly change of 8.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$12.60 Million | +2.95% |
| 2025 | CA$12.24 Million | +6.92% |
| 2024 | CA$11.44 Million | +1.51% |
| 2023 | CA$11.27 Million | +2.83% |
| 2022 | CA$10.96 Million | +8.32% |
| 2021 | CA$10.12 Million | +25.61% |
| 2020 | CA$8.06 Million | +5.01% |
| 2019 | CA$7.67 Million | +25.30% |
| 2018 | CA$6.12 Million | -3.65% |
| 2017 | CA$6.36 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Big Pharma Split Corp Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.60 Million USD |
| MoneyControl | $12.60 Million USD |
| MarketWatch | $12.60 Million USD |
| marketcap.company | $12.60 Million USD |
| Reuters | $12.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Big Pharma Split Corp Class A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.